Tarsus Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on eye care. The company develops and commercializes therapies for diseases of the ocular surface, with its lead product addressing demodex blepharitis, a common eyelid condition caused by Demodex mites. Tarsus Pharmaceuticals also advances additional ophthalmology assets and supports a broader eye-care franchise aimed at treating unmet needs in outpatient and specialist settings. Its business combines drug development, regulatory execution, and commercial distribution, making it an important participant in the ophthalmology and specialty pharmaceuticals market. Headquartered in Irvine, California, Tarsus Pharmaceuticals Inc. concentrates on transforming proven science into targeted treatments for patients and eye-care providers.
Website17700 Laguna Canyon Road
Irvine, CA, 92618
United States
Elizabeth Yeu Lin, Chief Medical Officer, on September 04, 2026, sold 13,953 shares in Tarsus Pharma
Seshadri Neervannan, Chief Operating Officer, on September 04, 2026, sold 4,564 shares in Tarsus Pha
Investors talking about TARS also mention
What share of all stock conversation is about TARS?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% new | 0% 0 | 0% +0 | 0% 0 |
Of the messages about TARS that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | 100% | 100% 0 | 95.65% +2.63 | 78.76% -11.16 | ||
| Bearish | 0% | 0% 0 | 4.35% -2.63 | 21.24% +11.16 |
Of the messages about TARS that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Analysts | — | 66.67% | 25.64% | 18.44% | ||
| Announcements | — | 33.33% | 16.92% | 46.2% | ||
| Technical Analysis | — | 0% | 37.44% | 23.1% | ||
| Earnings | — | 0% | 1.54% | 6.8% | ||
| Macro | — | 0% | 18.46% | 4.92% | ||
| Controversies | — | 0% | 0% | 0.54% |
Of the messages about TARS, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 20% | 19.05% | 84.55% | 79.2% | ||
| Newcomers | 80% | 80.95% | 15.45% | 20.8% |